The earnings call reflected a strong performance in key segments like Imaging and Varian, with significant revenue and EPS growth, leading to a positive outlook revision. However, challenges such as tariff impacts and market issues in China were noted. Despite these challenges, the company's robust performance and strategic advancements contribute to a positive sentiment.

Company Guidance

During the Siemens Healthineers Q3 2025 earnings call, the company reported a robust performance with a 7.6% growth in revenue across all regions and a significant 23% increase in adjusted EPS to EUR 0.64 per share. Despite a EUR 100 million headwind from tariffs, Siemens Healthineers achieved strong margin expansion, particularly in Imaging, which saw a nearly 12% revenue growth and a 21% margin. Varian also performed well with a 9% increase in comparable revenue and an 18.8% margin, marking a recovery from Q2. Advanced Therapies grew with a 10.5% margin, while Diagnostics saw a slight revenue decline but improved margins to 9.2%. The equipment book-to-bill ratio was solid at 1.09, and free cash flow remained strong, reducing the leverage factor below 3x for the first time since acquiring Varian. The company raised its fiscal year 2025 outlook, expecting revenue growth of 5.5% to 6% and adjusted EPS between EUR 2.30 and EUR 2.45, highlighting its resilience and strategic focus on innovation.

Strong Revenue Growth

In Q3, Siemens Healthineers grew by 7.6% with all regions contributing positively. Adjusted EPS grew by 23% to EUR 0.64 per share, supported by strong margin expansion despite tariff impacts.

Imaging and Varian Performance

Imaging achieved impressive revenue growth of almost 12% with margins improving to 21%. Varian continued its growth path with 9% comparable revenue growth and a strong 18.8% margin recovery.

Successful Diagnostics Transformation

The Atellica franchise, part of the Diagnostics business, is growing double digits and accounts for 60% of core lab revenues. Margin expansion is on track despite a slightly negative growth.

Free Cash Flow and Deleveraging

Free cash flow was strong, enabling leverage to drop below 3x for the first time since the Varian acquisition.

Raised Outlook for Fiscal Year 2025

Due to strong performance and certainty on tariffs, Siemens Healthineers raised its outlook for fiscal year 2025, expecting revenue growth of 5.5% to 6% and adjusted EPS between EUR 2.30 and EUR 2.45.

Siemens Healthineers AG Unsponsored ADR (SMMNY) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

Daily Earnings Calendar >

SMMNY Earnings History

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change	Slides	Play Transcript
Nov 05, 2025	2025 (Q4)	0.41 / -	0.36	―	―	―
Jul 30, 2025	2025 (Q3)	0.31 / 0.37	0.281	30.60% (+0.09)
May 07, 2025	2025 (Q2)	0.31 / 0.32	0.296	7.43% (+0.02)
Feb 06, 2025	2025 (Q1)	0.24 / 0.26	0.265	-0.38% (>-0.01)
Nov 06, 2024	2024 (Q4)	0.35 / 0.36	0.31	16.13% (+0.05)
Jul 31, 2024	2024 (Q3)	0.28 / 0.28	0.29	-3.10% (>-0.01)
May 07, 2024	2024 (Q2)	0.28 / 0.30	0.236	25.42% (+0.06)	―	―
Feb 01, 2024	2024 (Q1)	0.24 / 0.27	0.257	3.11% (<+0.01)	―	―
Nov 08, 2023	2023 (Q4)	0.31 / 0.31	0.326	-4.91% (-0.02)	―	―
Aug 02, 2023	2023 (Q3)	0.28 / 0.29	0.218	33.03% (+0.07)	―	―

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed

SMMNY Earnings-Related Price Changes

Report Date	Price 1 Day Before	Price 1 Day After	Percentage Change
Jul 30, 2025	$27.96	$28.41	+1.61%
May 07, 2025	$26.88	$26.48	-1.49%
Feb 06, 2025	$28.00	$29.33	+4.75%
Nov 06, 2024	$26.11	$27.24	+4.33%

Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Siemens Healthineers AG Unsponsored ADR (SMMNY) report earnings?

Siemens Healthineers AG Unsponsored ADR (SMMNY) is schdueled to report earning on Nov 05, 2025, TBA (Confirmed).

What is Siemens Healthineers AG Unsponsored ADR (SMMNY) earnings time?

Siemens Healthineers AG Unsponsored ADR (SMMNY) earnings time is at Nov 05, 2025, TBA (Confirmed).

Where can I see when companies are reporting earnings?

You can see which companies are reporting today on our designated earnings calendar.

What companies are reporting earnings today?

You can see a list of the companies which are reporting today on TipRanks earnings calendar.

What is SMMNY EPS forecast?

SMMNY EPS forecast for the fiscal quarter 2025 (Q4) is 0.41.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing